NPR: Pfizer vaccine’s protection against COVID wanes quickly in kids ages 5-11, study says
Researchers from the New York State Department of Health have found the low-dose version of the Pfizer-BioNTech COVID-19 vaccine given to children ages 5-11 to be less likely to prevent infection compared to the high-dose version given to people past the age of 12. Although all doses were shown to provide similar levels of protection against severe illness, kids ages 5-11 only had a 12% rate of preventing COVID-19 infection. This pales in comparison to what the study found for this rate to be in older children and adults. Adults had a 66% rate of averting transmission and children ages 12-17 had a 51% rate. These findings emphasize the importance of researching alternative vaccines for young children and the continued need to take COVID-19 precautions such as wearing masks and social distancing. The full article by Vanessa Romo and Rob Stein can be read here on NPR. For more on COVID-19 vaccines click here.